IV. TBI-DOSIMETRY

Absolute dose

Dosemeter, detector and cable.

Dose monitor and absorbed dose calibration.

Accuracy.

Relative dose

Beam fluence profile.

Quasi primary radiation.

Attenuation and scatter, phantom geometry.

Depth dose, depth dose homogeneity.

Tissue heterogeneity, lung corrections.

Dose modifier, partial shielding, bolus, compensators.

Surface dose, scatter screen/spoiler.

In-vivo dosimetry

Detectors.

Calibration.


RECOMMENDATIONS - TBI DOSIMETRY

  1. As a general rule, all dose measurements have to be performed under TBI conditions, in water and as close to the real treatment situation as possible. Water will be used as a reference material. If a plastic substance is used, the measurement will be related to water. All relative measurements have to be related to the calibration point.
  2. The dosimeters must be calibrated periodically against the national standards and the recommendations of the recognized dosimetric protocol (NACP, IAEA, SEFM, IPSM, etc.) must be followed[47-50].
  3. An estimation of the effect of the irradiation of cables and stems should be made.
  4. The absolute dose calibration must be done using a phantom with at least 30 x 30 x 20 cm3. The depth of the measurement point should be larger than the depth of maximum dose, and preferably 10 cm which corresponds to the average midthickness of a patient. The dose unit is Gy.
  5. The dose monitor should be calibrated against dose measurement at the centre of the square calibration phantom.
  6. The estimated accuracy required should be stated. The accuracy should be as good as possible, preferably below  ±5% (95% confidence level).
  7. At least 4 beam profiles, lateral and diagonal, should be measured.
  8. Beam flattening must be checked, and corrected, if necessary by using additional flattening filters.
  9. Free in air measurements should be avoided.
  10. Measurements of beam profiles should be made with a build-up cap of 10 cm water equivalent thickness and related to the reference dose at calibration conditions.
  11. Wall and floor scatter contributions must be considered.
  12. The inverse square law must be verified within the range of distances foreseen in TBI treatments. If the differences are higher than 2%, an empirical curve should be determined.
  13. The lack of backscatter due to finite thickness should also be taken into account.
  14. To consider the different volumes of parts of the patient's body, measurements under total and partial scattering conditions should be made.
  15. In order to describe the influence on depth dose, measurements should be performed with phantoms of different sizes and thicknesses, at different source-skin distances. Dose data, in addition to the central axis curve, should be measured, because differences may not be negligible.
  16. Lung dose correction factors have to be determined for the thickness of the thorax wall, lung density as well as the shielding thickness and size.
  17. Partial shielding of the lung must be used in every session in order to keep the same set of TBI parameters during all fractions.
  18. In order to achieve a better dose homogeneity, an appropriate thickness of a suitable material (spoiler) may be placed in front of the patient to ensure electronic equilibrium at the patient's skin, when necessary.
  19. An in-vivo dosimetry system should be available to check the prescribed dose or to monitor the machine.
  20. Calibration of detectors for in-vivo dosimetry must be performed at suitable phantoms and under TBI treatment conditions in order to consider all relevant factors.

[ Back ] [ Index ] [ Next ]